Erythrocyte rheological changes in obese patients: Influence of hyperinsulinism

International Journal of Obesity

Volumn 20, Issue 9, 1996, Pages 814-819

  Valensi, P ^a,b   Paries, J ^a   Maheo, P ^a   Gaudey, F ^a   Attali, J R ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL JEAN VERDIER   (France)

Author keywords

Hyperinsulinemia; Hypertension; Insulin resistance; Obesity; Red blood cells; Rheology

Indexed keywords

C PEPTIDE;

ADULT; ARTICLE; BLOOD RHEOLOGY; BODY MASS; BODY WEIGHT; CHEMICAL COMPOSITION; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE FILTERABILITY; FEMALE; HEMATOCRIT; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OBESITY; PLASMA FACTOR; PRIORITY JOURNAL; RISK FACTOR;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; CREATININE; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMORHEOLOGY; HUMANS; HYPERINSULINISM; MALE; OBESITY; URIC ACID;

EID: 0029747140     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hubert HB et al. Obesity in an independent risk factor for cardiovascular disease: a 26-year follow up of participants in the Framingham heart study. Circulation 1993; 67: 968-977.
2. Stolz JF. Cardiovascular diseases, risk factors and hemorheological parameters. Clin Hemorheol 1981; 3: 257-267.
3. Hanss M. Erythrocyte filterability measurement by the initial flow rate method. Biorheology 1983; 20: 199-212.
4. Garnier M et al. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition. Metabolism 1990; 39: 794-798.
5. Juhan I et al. Effects of insulin on erythrocyte deformability in diabetics-Relationship between erythrocyte deformability and platelet aggregation. Scand J Clin Lab Invest 1981; 41 (suppl 156): 159-164.
6. Oka S. Physical theory of permeability of vascular walls in relation to atherogenesis. Biorheology 1976; 16: 203-209.
7. Caro CG. Arterial fluid dynamics and atherogenesis. Clin Hemorheol 1982; 2: 131-136.
8. Niimi H. Blood rheology at stagnation. Clin Hemorheol 1981; 1: 276. (Abstract)
9. Ernst E et al. Cardiovascular risk factors and hemorheology. Physical fitness, stress and obesity. Atherosclerosis 1986; 59: 263-269.
10. Le Devehat C, Khodabandelhou T, Dougny M. Etude des paramètres hémorhéologiques dans l'obésitisolée. Diabète Métab 1992; 18: 43-47.
11. Gelmini G et al. Whole blood filterability in elderly obese women. Acta Diabetol Lat 1987; 24: 199-203.
12. Cacciari E et al. Haemorheologic and fibrinolytic evaluation in obese children and adolescents. Eur J Pediatr 1988; 147: 381-384.
13. Craveri A et al. Le alterazioni emoreologiche negli obesi. Min Med 1987; 78: 899-906.
14. Koutsouris D, Hanss M, Stalak R. Determination of erythrocyte transit times through a 5μ "Nuclepore" filter. Biorheology 1983; 20: 779-788.
15. Schmid-Schonbein H et al. New hemorheological techniques for the routine laboratory. Clin Hemorheol 1982; 2: 93-105.
16. Fanari P et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes 1993; 17: 487-494.
17. Meade TW et al. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentration. BMJ 1979; i: 153-156.
18. Vague Ph et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative weight in normal and obese subjects. Metabolism 1986; 35: 250-253.
19. Rillaerts E, Vansant G, Van Gaal L, de Leeuw I. Effect of weight reduction on blood viscosity parameters in obese women. Clin Hemorheol 1989; 9: 983-987.
20. Craveri A et al. Hemorheological changes in obese children and the effect of weight loss. Clin Hemorheol 1982; 12: 573-578.
21. Beguinot F et al. Alteration of erythrocyte membrane lipid fluidity in human obesity. J Clin Endocrinol Metab 1985; 60: 1226-1230.
22. Garnier M et al. Interest of sodium red blood cell content measurement in non insulin dependent diabetic patients with hemorheological abnormalities. Clin Hemorheol 1995; 15: 325-333.
23. Rillaerts E et al. Blood viscosity in human obesity: relation to glucose tolerance and insulin status. Int J Obes 1989; 13: 739-749.
24. Dutta-Ray AK, Ray TK, Sinha AK. Control of erythrocyte membrane micro viscosity by insulin. Biochim Biophys Acta 1985; 816: 187-190.
25. Alessi MC et al. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb Haemost 1988; 60: 491-494.
26. Ganrot PO. Insulin resistance syndrome: possible key role of blood flow in resting muscle. Diabetologia 1993; 36: 876-879.
27. Laasko M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990; 85: 1844-1852.
28. Baron AD, Laasko M, Brechtel G, Edelman SV. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in non-insulin-dependent diabetic subjects. Effects of insulin therapy. J Clin Invest 1991; 87: 1186-1194.
29. Moan A et al. Relationship between hemorrheological factors and insulin sensibility in healthy young men. Metabolism 1994; 43: 423-427.
30. Berlin E et al. Dietary fat and hormonal effects on erythrocyte membrane fluidity and lipid composition in adult women. Metabolism 1989; 38: 790-796.
31. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes 1979; 2: 154-160.
32. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 91/2 year follow-up of the Helsinki Policemen Study population. Acta Med Scand 1985; 701 (suppl): 38-52.
33. Fontbonne A et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11 year follow-up of the Paris Prospective Study. Diabetologia 1989; 32: 300-304.
34. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.